Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree?
Moran
Gordon
G
Dillon
Jayne
J
Green
Jonathan
J
D001379:Azathioprine / Q000009:adverse effects* / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000628:therapy; D016399:Lymphoma, T-Cell / Q000139:chemically induced* / Q000628:therapy; D008297:Male; D019804:Mesalamine / Q000627:therapeutic use; D011379:Prognosis; D013160:Splenic Neoplasms / Q000139:chemically induced* / Q000628:therapy; D055815:Young Adult
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D019804:Mesalamine; D001379:Azathioprine